Ipca Laboratories Limited
IPCALAB
Rank in Stocks
#3405
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Share Price
$20.02
Last synced: 2026-10-19
Market Cap
$5.08B
Change (1 day)
-1.65%
Change (1 year)
38.46%
Country
IN
Trade Ipca Laboratories Limited (IPCALAB)
Category
Healthcare
Stock split history for Ipca Laboratories Limited (IPCALAB)
Ipca Laboratories Limited stock (symbol: IPCALAB) underwent a total of 3 stock splits.
The most recent stock split occurred on Jan 10, 2022.
One IPCALAB share bought prior to Jan 28, 2005 would equal to 20 IPCALAB shares today.
The most recent stock split occurred on Jan 10, 2022.
One IPCALAB share bought prior to Jan 28, 2005 would equal to 20 IPCALAB shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| 2022-01-10 | 2:1 | x2 | x20 |
| 2010-03-22 | 5:1 | x5 | x10 |
| 2005-01-28 | 2:1 | x2 | x2 |
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
